# A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

> **NCT01155388** · PHASE3 · TERMINATED · sponsor: **AMAG Pharmaceuticals, Inc.** · enrollment: 14 (actual)

## Conditions studied

- Iron Deficiency Anemia
- Nondialysis-dependent Chronic Kidney Disease

## Interventions

- **DRUG:** Ferumoxytol
- **DRUG:** Oral Iron

## Key facts

- **NCT ID:** NCT01155388
- **Lead sponsor:** AMAG Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10-17
- **Primary completion:** 2014-06-24
- **Final completion:** 2014-06-24
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Several factors contributed to significant challenges in enrollment and led the Sponsor to discontinue the AMAG-FER-CKD-252 study as designed.
- **Last updated:** 2022-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01155388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01155388, "A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01155388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*